Blog by Sanwariya Packaging

Your Trusted Partner in Packaging

Learn About Our Vision for the Future And Grow with Us.

Your Trusted Partner in Pharma Packaging

Learn about our vision for the future and grow with us.

Your Trusted Partner
in Pharma Packaging

Learn about our vision for the future and grow with us.

Know More

Day: February 19, 2026

Importance of foil coatings in hot and humid climates

Moisture is invisible, but in pharmaceutical packaging, it is one of the most frequent root causes of product instability, shelf-life reduction, and post-approval failures. Issues such as tablets softening, capsules losing potency, coating degradation, or unexpected stability failures are often traced back to one critical factor: inadequate moisture protection from the packaging system.

This is where the Moisture Transmission Rate (MTVR) becomes decisive. Understanding how foil structure directly influences MTVR enables pharmaceutical companies to make informed, preventive pharmaceutical packaging decisions—particularly for moisture-sensitive formulations and products distributed across high-humidity or long-transit markets.

This article explains MTVR in clear, practical terms, connects barrier science to real-world pharmaceutical risk, and shows how selecting the right foil structure protects product quality, regulatory compliance, and patient safety.

What Is the Moisture Transmission Rate (MTVR)?

Moisture Transmission Rate (MTVR) measures the amount of water vapor that can pass through a packaging material over a defined area and time under controlled conditions.

In practical pharmaceutical terms:

  • Low MTVR = strong moisture barrier and higher product protection
  • High MTVR = increased risk of moisture ingress and product degradation

Even minimal moisture exposure can:

  • Reduce shelf life
  • Alter drug performance
  • Trigger stability failures during storage or transport
For moisture-sensitive products, MTVR is not a secondary specification—it is a critical quality attribute influencing approval, performance, and market reliability.

Why Foil Structure Directly Determines MTVR Performance

Pharmaceutical foil is not a single material layer. Its structure—how multiple layers work together—defines overall moisture resistance.

A typical pharmaceutical foil structure—such as blister foils,cold forming foils, or strip laminated foils—may include:

  • Aluminum foil (primary moisture barrier)
  • Protective coatings or lacquers
  • Heat-seal layers
  • Optional polymer films in multi-layer foil or specialty structures

Each layer performs a distinct function. A well-engineered structure slows moisture migration at multiple points, while a weak or incompatible structure allows vapor to penetrate—even when aluminum thickness appears adequate.

Key insight:
Two foils with similar thickness can show vastly different MTVR values because barrier performance depends on structure integrity, not thickness alone.

How Individual Foil Layers Influence Moisture Protection

1. Aluminum Layer — The Primary Barrier

  • Acts as the main moisture and oxygen barrier
  • Defect-free aluminum significantly reduces vapor transmission
  • Thickness consistency and pinhole control are critical
While aluminum provides the core barrier, it cannot perform alone.

2. Coatings & Lacquers — Barrier Stability and Durability

  • Protect aluminum from mechanical and chemical stress
  • Reduce micro-crack formation during forming and handling
  • Improve resistance to long-term humidity exposure
Poor or incompatible coatings can compromise barrier performance even when aluminum quality is high.

3. Sealant Layers — The Most Common Failure Point

Enable airtight sealing between foil and blister material

  • Directly affect moisture ingress at seal areas
  • Must be compatible with forming films and sealing parameters
Fact:
Many moisture-related failures occur not because the aluminum layer failed, but because the seal layer allowed moisture pathways to form.

Standard Foil vs High-Barrier Foil: Why Structure Matters

AspectStandard Foil StructureHigh-Barrier Foil Structure
Moisture ResistanceModerateVery high
Long-Term StabilityLimited in humid zonesConsistent across climates
Suitability for ExportsShort or controlled routesLong-distance, high-risk markets
Regulatory ConfidenceConditionalStrong, data-backed

High-barrier structures are engineered to perform reliably under sustained humidity stress—not just initial testing conditions.

When High-Barrier Foil Structures Become Mandatory

High-barrier pharmaceutical foils—such as cold forming foils and advanced multi-layer foils—are essential when:

  • The formulation is moisture-sensitive
  • Shelf life exceeds 24 months
  • Distribution includes Climatic Zones III & IV
  • Products face long transit, port storage, or uncontrolled warehousing

Markets across Asia, Africa, Latin America, and coastal regions routinely expose pharmaceutical products to prolonged high humidity. In these environments, standard foil structures may pass early stability studies yet fail during real-world storage.

MTVR Testing and Evaluation: What Regulators Expect

MTVR performance cannot be assumed—it must be measured, validated, and documented.

Key evaluation approaches include:

  • Moisture transmission testing under controlled laboratory conditions
  • Stability studies aligned with climatic zone requirements
  • Seal integrity and aging assessments

Regulatory and quality teams rely on this data to:

  • Approve packaging during product registration
  • Justify export-readiness claims
  • Support long-term stability commitments
Without validated MTVR performance, packaging approval and lifecycle management become uncertain.

Common Real-World Failures Linked to Poor MTVR Selection

Across domestic and export markets—supported by advanced manufacturing and quality controls at our infrastructure facilities—the same patterns repeatedly emerge:

  • Stability passes initially but fails after months in humid storage
  • Tablets stick, soften, or discolor before expiry
  • Market complaints arise despite compliant formulations
  • Costly revalidation triggered by post-approval packaging changes
In most cases, the root cause is not formulation weakness—but foil structure mismatched to environmental exposure.

Choosing the Right Foil Structure

Instead of asking “Is this foil thick enough?”, pharmaceutical teams should ask:

  • How moisture-sensitive is the formulation?
  • Which climatic zones will the product encounter?
  • What is the total storage and transit duration?
  • Is the seal layer compatible with the blister material?
  • Does the supplier provide validated MTVR and stability data?

Selecting the correct foil structure is a preventive quality decision, not a corrective one.

Business and Compliance Impact of Correct MTVR Selection

Choosing the right foil structure delivers measurable value:

  • Fewer stability failures and deviations
  • Faster regulatory approvals
  • Reduced recall and rejection risk
  • Lower long-term costs compared to revalidation
  • Stronger patient trust and brand credibility
Underestimating MTVR often results in hidden costs that far exceed the initial savings from lower-grade packaging.

Key Takeaway

MTVR is not merely a laboratory value—it reflects how effectively a pharmaceutical product is protected throughout its entire lifecycle.

Foil structure directly influences:

  • Moisture resistance
  • Shelf-life reliability
  • Export success
  • Regulatory confidence

Understanding and selecting the right barrier structure ensures medicines remain safe, effective, and compliant—regardless of where they are manufactured, stored, or distributed.

At Sanwariya Packaging, barrier performance is approached as a stability and compliance solution, not just a material specification. Because in pharmaceutical packaging, what cannot be seen—like moisture—often matters the most. For technical discussions or project requirements, teams may get in touch or request a quote.